Your search returned 3 results.

Results
	1.	Didymin ameliorates hepatic injury through inhibition of MAPK and NF-κB pathways by up-regulating RKIP expression. [electronic resource] by Huang, Quanfang Bai, Facheng Nie, Jinlan Lu, Shengjuan Lu, Chunyuang Zhu, Xunshuai Zhuo, Lang Lin, Xing Producer: 20170414 In: International immunopharmacology vol. 42 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Didymin Alleviates Hepatic Fibrosis Through Inhibiting ERK and PI3K/Akt Pathways via Regulation of Raf Kinase Inhibitor Protein. [electronic resource] by Lin, Xing Bai, Faicheng Nie, Jinlan Lu, Shengjuan Lu, Chunyuang Zhu, Xunshuai Wei, Jinbin Lu, Zhongpeng Huang, Quanfang Producer: 20170208 In: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology vol. 40 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Didymin induces apoptosis through mitochondrial dysfunction and up-regulation of RKIP in human hepatoma cells. [electronic resource] by Wei, Jinbin Huang, Quanfang Bai, Facheng Lin, Jun Nie, Jinlan Lu, Shengjuan Lu, Chunyuang Huang, Renbin Lu, Zhongpeng Lin, Xing Producer: 20170207 In: Chemico-biological interactions vol. 261 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search